ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) price is hovering lower on Monday, September 13, dropping -4.12% below its previous close.
A look at today’s price movement shows that the recent level at last check reads $1.82, with intraday deals fluctuating between $1.81 and $1.94. The company’s 5Y monthly beta was ticking 1.99. Taking into account the 52-week price action we note that the stock hit a 52-week high of $5.95 and 52-week low of $1.26. The stock subtracted -2.67% on its value in the past month.
ZIOPHARM Oncology Inc., which has a market valuation of $396.47 million, is expected to release its quarterly earnings report Nov 03, 2021 – Nov 08, 2021. Analysts tracking ZIOP have forecast the quarterly EPS to shrink by -0.13 per share this quarter, while the same analysts predict the annual EPS to hit -$0.44 for the year 2021 and up to -$0.45 for 2022. In this case, analysts estimate an annual EPS growth of -15.80% for the year and -2.30% for the next year.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give ZIOP a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that ZIOP’s price is at present 0.61% off the SMA20 and -15.64% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 45.09, with weekly volatility standing at 14.37%. The indicator jumps to 11.69% when calculated based on the past 30 days. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)’s beta value is holding at 1.97, while the average true range (ATR) indicator is currently reading 0.20. Considering analysts have assigned the stock a price target range of $3.00-$7.50 as the low and high respectively, we find the trailing 12-month average consensus price target to be $4.33. Based on this estimate, we see that today’s price at last check is roughly -71.43% off the estimated low and -328.57% off the forecast high. Investors will no doubt be excited to see the share price fall to $3.25, which is the median consensus price, and at that level ZIOP would be -85.71% from recent price.
Turning out attention to how the ZIOPHARM Oncology Inc. stock has performed in comparison to its peers in the industry, here’s what we find: ZIOP’s stock is -4.12% on the day and -26.61% in the past 12 months. Also, Bristol-Myers Squibb Company (BMY) is currently showing down trend of -0.91% while its price kept floating at 6.53% over the past year. Elsewhere in the market, the S&P 500 Index has stumbled -0.10% in today’s early trading, with the Dow Jones Industrial also seeing a negative session so far with -0.43%.
An analysis of the ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) stock in terms of its daily trading volume indicates that the 3-month average is 3.08 million.
Current records show that the company has 214.43M in outstanding shares. The insiders’ percentage holdings are 1.60% of outstanding shares while the percentage share held by institutions stands at 57.50%. But the -27.78% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.